J-L Vanoverschelde (Brussels, Belgium) discusses the techniques used to assess the severity of aortic regurgitation.
J-L Vanoverschelde (Brussels, Belgium) discusses the techniques used to assess the severity of aortic regurgitation.
G El-Khoury (Brussels, Belgium) explains his approach to assessing the regurgitant aortic valve for repair.
M Redmond (Dublin, Ireland) introduces the factors influencing the choice of aortic valve repair or replacement.
T David (Toronto, Canada) outlines the connective tissue disorders which affect the ascending aorta.
R Petersen (Copenhagen, Denmark) gives a detailed description of the VATS lobectomy programme in Copenhagen, including a video demonstration of a right upper lobectomy.
M Jahangiri (London, UK) describes her technique for mini-AVR and reviews the results.
M Redmond (Dublin, Ireland) describes several techniques for aortic valve repair.
P Dartevelle (Paris, France) describes how to perform carinal resections and reconstructions.
A Zuckermann (Vienna, Austria) gives an overview of VAD patient management, with particular emphasis on potential complications.
M Redmond (Dublin, Ireland) discusses the bicuspid aortic valve syndrome, including underlying pathogenesis and indications for intervention.
S Ahmad (London, UK) explains the current techniques used in stereotactic ablative radiotherapy (SABR). S Barnard (Newcastle, UK) considers limited resection in poor lung function. A panel discussion about the optimal treatment strategy follows.
A Simon (London, UK) discusses the changing pattern of heart transplantation urgency and the likelihood of a patient on a device receiving a transplant.
A Vahanian (Paris, France) gives an overview of the 2012 European valve guidelines, with emphasis on patient evaluation.
D Gonzalez-Rivas (Coruna, Spain) describes his uniportal VATS lobectomy technique.
J O’Connor (Baltimore, USA) presents case studies for audience discussion about management.
Prakash Punjabi (London, UK) presents the evidence for mitral valve intervention in the failing heart.
P Kappestein (Rotterdam, Netherlands) discusses the 2012 ESC-EACTS European guidelines for intervention in asymptomatic severe aortic stenosis.
M Redmond (Dublin, UK) describes the anatomy of the aortic root as a functional unit.
S Jordon (London, UK) and J Maguire (Liverpool, UK) debate whether patients with single station N2 disease should have surgical resection.
G MacGowan (Newcastle, UK) briefly addresses the issue of declining heart transplant numbers in the UK.
J Takkenberg (Rotterdam, Netherlands) considers valve prosthesis choice according to the 2012 ECS-EACTS European guidelines.
S Schueler (Newcastle, UK) reviews the history of heart transplantation before arguing that LVAD therapy is now the new gold standard.
P Kappestein (Rotterdam, Netherlands) discusses the 2012 European guidelines for transcatheter aortic valve implantation.
H Vohra (Brussels, Belgium) considers the influence of a higher valve gradient on long-term outcome after aortic valve repair.
S Rehman (Oxford, UK) discusses intra-operative imaging techniques in CABG surgery. S Westaby (Oxford, UK) argues that probing is sufficient to assess graft patency. R Haaverstad (Bergen, Norway) is in favour of graft assessment with transit time flow measurement and…
PM de la Santa (Vigo, Spain) discusses thoracic trauma from a European perspective.
M Abdelaziz (Coventry, UK) looks at his unit’s experience of tricuspid valve repair using a variety of techniques.
H Vohra (Brussels, Belgium) talks about the effect of mild residual aortic regurgitation after aortic valve repair.
R Steyn (Birmingham, UK) discusses pre-hospital trauma care and presents a number of cases to the audience for discussion.
M Burch (London, UK) discusses cardiac transplantation in congenital heart patients.
M Murzi (Massa, Italy) describes a single centre experience with minimally invasive aortic valve replacement via right anterior minithoracotomy compared with ministernotomy.
M Struber (Leipzig, Germany) describes off-pump LVAD insertion before discussing biventricular support.
S Stamenkovic (Newcastle, UK) discusses how to train in VATS lobectomies, looking at other professions and the importance of simulation.
E Verrier (Washington, USA) discusses the transition from training to practice, looking at possible solutions in the modern era.
J Dunning (Cambridge, UK) argues that cardiac transplantation remains the gold standard for end-stage heart failure treatment in the UK.
I Radotra (Sheffield, UK) considers whether prosthetic size matters in aortic valve replacement.
T Tsitsias (Leicester, UK) presents his unit’s results comparing extended pleurectomy decortication with VATS debulking for malignant pleural mesothelioma.
S Naik (Nottingham, UK) shares his experience of bioprosthetic aortic valve implantation in a supra-annular tilted position in order to avoid patient-prosthesis mismatch.
J Begg (Heartware) describes the Heartware HVAD and MVAD devices for mechanical circulatory support.
J O’Connor (Baltimore, USA) describes his experience of cardiothoracic trauma in the biggest centre in the USA.
D Aktuerk (Coventry, UK) presents single surgeon outcomes of cryoablation for atrial fibrillation.
S Schueler (Newcastle, UK) discusses destination therapy as an option for heart failure in the UK.
S Livesey (Southampton, UK) presents one year data from the European Registry of the saddle-shaped Carpentier-Edwards Physio II ring.
R Steyn (Birmingham, UK) introduces a cardiothoracic trauma forum. J O’Connor (Baltimore, USA) explains the Maryland model of trauma care. K Porter (Birmingham, UK) describes major trauma centres and networks in England.
R Capoun (Bristol, UK) reports on a multicentre randomised trial of shortening cardioplegic arrest time in combined cardiac surgery.
N Ismail (Leicester, UK) audits the need for permanent insertion after cardiac surgery in a single centre.
J Parameshwar (Cambridge, UK) discusses referral for heart transplantation based on UK guidelines published in 2011.
U Opfermann (Berlin, Germany) describes developments in Berlin Heart technology.
S Stamenkovic (Newcastle, UK) and R Milton (Leeds, UK) debate whether patients with lung cancer should have a direct surgical referral.
N Moat (London, UK) looks at combining the SCTS database and the TAVI registry to allow comparison between aortic intervention groups.
O Alfieri (Milan, Italy) gives an overview of the 2012 European valve guidelines for asymptomatic mitral regurgitation, and then proceeds to look at tricuspid regurgitation.
S Grant (Manchester, UK) explains how the SCTS database can be used for dynamic clinical prediction models, using mitral vale prosthesis choice as an example. G Hickey (Manchester, UK) looks at the history of prediction models and how dynamic models…
R Venkateswaran (Manchester, UK) discusses the principles of brain dead donor management.
A Vahanian (Paris, France) discusses patient selection for mitraclip use. O Alfieri (Milan, Italy) describes the international clinical experience. S Livesey (Southampton, UK) puts forward the case for surgical repair.
D Talbot (Newcastle, UK) discusses ex-vivo cardiac perfusion, demonstrating that organ reanimation is possible after death.
A Szczap (Bristol, UK) looks at renal function after minimally invasive versus conventional mitral valve surgery.
S Bello (Cambridge, UK) looks at the natural history of functional tricuspid regurgitation if left unrepaired during mitral valve surgery.
D Taggart (Oxford, UK) gives his perspective on the 2010 European revascularisation guidelines, based on evidence from the literature. A discussion follows.
J Dunning (Middlesbrough, UK) describes how he set up a VATS lobectomy programme as a mixed practice cardiothoracic surgeon.
G. Ellison (Liverpool & London, UK) discusses cardiac stem cells and myocyte regeneration.
P Kolh (Liege, Belgium) describes the development of the 2010 European revascularisation guidelines. He emphasises the importance of the heart team and evidence-based protocols. He explores the indications for the different treatment options in stable disease, updating the guidelines with…
B Bridgewater (Manchester, UK) explains how the UK database is used to analyse mitral valve repair rates and outcomes. A discussion follows.
N Patel (Bristol, UK) reports on a study of red cell washing in a porcine model , attempting to reduce the incidence of transfusion related acute lung injury.
B Bridgewater (Manchester, UK) explains some of the current initiatives around the use of the UK database.
N Roberts (London, UK) gives an update on anti-platelet use in coronary bypass surgery patients.
P Punjabi (London, UK) examines the role of left ventricular shape in mitral valve repair, and techniques used to optimise this shape.
H Pilegaard (Skejby, Denmark) discusses the surgical management of pectus excavatum. M Yuksel (Istanbul, Turkey) considers minimally invasive repair of pectus carinatum. Chest wall reconstruction for malignant processes is then explored by J-M Wihlm (Strasbourg, France) before P Dartevelle (Paris,…
G Hickey (Manchester, UK) explains the statistical handling of the SCTS database data.
D Hausenloy (London, UK) gives an update on the ERICCA trial of remote ischaemic preconditioning.
F Wells (Cambridge, UK) describes the structure of the mitral valve and its complexity as a functional unit.
K Caston (London, UK) explains some of the fundamental changes to commissioning in the new NHS.
G MacGowan (Newcastle, UK) considers the optimal investigation and medical management of patients in heart failure.
D Hildick-Smith (Brighton, UK) discusses the FREEDOM trial and other diabetic data in revascularisation, from a cardiologist’s perspective.
J-L Vanoverschelde (Brussels, Belgium) examines the causes of early and late failure after mitral valve repair.
G Massard (Strasbourg, France) considers the role of surgery in aspergillosis.
P Kolh (Leige, Belgium) promotes the value of the heart team and questions whom should be involved. He considers patient information, medical ethics, time and risk stratification.
A Vahanian (Paris, France) looks at the indications for mitral valve repair, with emphasis on the 2012 European valve guidelines.
G Soppa (London, UK) compares his institution’s resullts with standard and mini-AVR.
D Hildick-Smith (Brighton, UK) gives an overview of the use of anti-platelet agents in patients underging PCI with stenting.
D Taggart (Oxford, UK) emphasises the need for a heart team to ensure that patients receive the most appropriate guideline-driven interventions.
O Alfieri (Milan, Italy) gives an overview of the goals of mitral valve repair and describes the different techniques used.
S James (London, UK) describes several flaps which can be used in sternal reconstruction.
M Khorsandi (Manchester, UK) reviews the North West of England experience with civilian trauma.
M Bhabra (Wolverhampton, UK) describes the local structure of his heart team.
F Wells (Cambridge, UK) explores the importance of surgical experience and the nature of the pathology when deciding on mitral valve repair or replacement.
N Moat (CRG, UK) explains the new NHS commissioning process.
A Vahanian (Paris, France) considers the 2012 European valve guidelines for asymptomatic aortic regurgitation.
N Howell (Birmingham, UK) looks at the timing of stroke after coronary surgery.
H Poon (Birmingham, UK) assesses the management of thoracic military injuries in a specialist centre.
E Verrier (Washington, UK) gives an overview of the results fr the use of left ventricular reconstruction in the STITCH trial.
B Bridgewater (Manchester, UK) explains the analysis of the UK database data and demonstrates visualisation of the data via the Blue Book Online. A comparison of single versus bilateral mammary usage in coronary revascularisation is then made.
R Patel (Coventry, UK) explains why redo mitral surgery is sometimes necessary and describes surgical tips and tricks.
C Munsch (HEE, UK) gives an overview of developments in cardiothoracic training.
N Khan (Wolverhampton, UK) gives an overview of current antiplatelet agents, their limitations, and looks at strategies to overcome these limitations.
E Verrier (Washington, USA) discusses the revascularisation heart team from a USA perspective.
T David (Toronto, Canada) discusses the problem of posterior mitral valve calcification, with a video demonstration of repair using a CorMatrix patch.
J Roxburgh (London, UK) puts outcome publication in context, giving the history of developments since 2003 and looking at how things will continue to evolve.
H Luckraz (Wolverhampton, UK) assesses whether decisions made by the heart team are enacted.
S Price (London, UK) looks at circumflex coronary artery injury during mitral valve repair.
J-L J Vanoverschelde (Brussels, Belgium) gives an overview of mitral valve assessment by echocardiography.
S Allard (London, UK) presents a national comparative audit of blood transfusion in cardiac surgery.
M Norell (Wolverhampton, UK) talks about the role of the revascularisation multidisclipinary heart team from a cardiology viewpoint.
J-L J Vanoverschelde (Brussels, Belgium) considers how much residual regurgitation is acceptable after mitral valve repair.
T David (Toronto, Canada) considers the evolution and future of aortic valve surgery.
F Wells (Cambridge, UK) tells how he avoids producing systolic anterior motion (SAM) in mitral valve repair.
C McDonald (AstraZeneca) describes the PLATO trial of ticagrelor vs clopidogrel in acute coronary syndrome. The CABG sub-group results are presented.
D Taggart (Oxford, UK) describes the VEST trial of external venous support for coronary bypass grafts.
S Price (London, UK) explains how to assess and manage systolic anterior motion (SAM) after mitral valve repair. A panel discussion follows.
R Di Bartolomeo (Bologna, Italy) reviews the approach to complex aortic disease, describing in detail his use of the frozen elephant trunk procedure using the E-vita graft. J Mascaro (Birmingham, UK) presents his results and demonstrates use of the Thoraflex…
A Carey (Plymouth, UK) looks at the impact of low preoperative haemoglobin on outcomes in patients undergoing urgent coronary bypass surgery.
A Vahanian (Paris, France) discusses the indications for intervention in aortic regurgitation and ascending aortic dilatation, based on the 2012 ESC/EACTS valve guidelines.
J Treiber (Thoratec) presents a vision for the future of ventricular assist device therapy.
J McGuigan (Belfast, UK) describes his experience of trauma in Northern Ireland.